Warning: The NCBI web site requires JavaScript to function. more...
A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.
Moore L, Remy V, Martin M, Beillat M, McGuire A.
Cost Eff Resour Alloc. 2010 Apr 30;8:7.
Related citations
Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland.
Szucs TD, Kressig RW, Papageorgiou M, Kempf W, Michel JP, Fendl A, Bresse X.
Hum Vaccin. 2011 Jul;7(7):749-56. Epub 2011 Jul 1.
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.
Brisson M, Pellissier JM, Camden S, Quach C, De Wals P.
Hum Vaccin. 2008 May-Jun;4(3):238-45. Epub 2010 May 25.
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM, Brisson M, Levin MJ.
Vaccine. 2007 Nov 28;25(49):8326-37. Epub 2007 Oct 17.
Cost effectiveness of herpes zoster vaccine in Canada.
Najafzadeh M, Marra CA, Galanis E, Patrick DM.
Pharmacoeconomics. 2009;27(12):991-1004. doi: 10.2165/11314010-000000000-00000.
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Hornberger J, Robertus K.
Ann Intern Med. 2006 Sep 5;145(5):317-25.
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
Armstrong EP.
J Manag Care Pharm. 2010 Apr;16(3):217-30. Review.
Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
Johnson RW.
Aging Clin Exp Res. 2009 Jun;21(3):236-43. Review.
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J, Jones J, Takeda A, Davidson P, Price A.
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.
Rothberg MB, Virapongse A, Smith KJ.
Clin Infect Dis. 2007 May 15;44(10):1280-8. Epub 2007 Apr 3.
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.
van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ.
Vaccine. 2009 Feb 25;27(9):1454-67. Epub 2009 Jan 9.
Estimating the number needed to vaccinate to prevent herpes zoster-related disease, health care resource use and mortality.
Brisson M.
Can J Public Health. 2008 Sep-Oct;99(5):383-6.
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.
Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T.
BMC Med. 2010 Jun 21;8:37.
Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
Ritchie M, Liedgens H, Nuijten M.
Clin Drug Investig. 2010;30(2):71-87. doi: 10.2165/11533310-000000000-00000.
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A.
BMC Infect Dis. 2010 Aug 3;10:230.
Community and patient values for preventing herpes zoster.
Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA.
Pharmacoeconomics. 2008;26(3):235-49.
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.
Gauthier A, Breuer J, Carrington D, Martin M, Rémy V.
Epidemiol Infect. 2009 Jan;137(1):38-47. Epub 2008 May 9.
Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
Bilcke J, Marais C, Ogunjimi B, Willem L, Hens N, Beutels P.
Vaccine. 2012 Jan 11;30(3):675-84. Epub 2011 Nov 24.
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.
Annemans L, Rémy V, Oyee J, Largeron N.
Pharmacoeconomics. 2009;27(3):231-45. doi: 10.2165/00019053-200927030-00006.
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D.
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on